These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 11603414

  • 1. Human immunoglobulin and the Guillain-Barre syndrome: new indication. An alternative to plasmapheresis.
    Prescrire Int; 2000 Oct; 9(49):142-3. PubMed ID: 11603414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.
    Chamouni P, Tamion F, Gueit I, Girault C, Lenain P, Varin R, Czernichow P.
    Transfus Apher Sci; 2003 Apr; 28(2):117-24. PubMed ID: 12679114
    [Abstract] [Full Text] [Related]

  • 4. Intravenous immunoglobulin and Guillain-Barré syndrome.
    Harel M, Shoenfeld Y.
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):281-7. PubMed ID: 16391403
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura.
    Zeidman LA, Fahey CD, Grinblatt DL, Harsanyi K.
    Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282
    [Abstract] [Full Text] [Related]

  • 7. [Intravenous immunoglobulin therapy for Guillain-Barré syndrome in Japan: changes in treatment after its inclusion in health insurance coverage].
    Nishimoto Y, Yuki N.
    Rinsho Shinkeigaku; 2004 Sep; 44(9):633-5. PubMed ID: 15515710
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional recovery of untreated human immunodeficiency virus-associated Guillain-Barré syndrome: a case report.
    Schreiber AL, Norbury JW, De Sousa EA.
    Ann Phys Rehabil Med; 2011 Nov; 54(8):519-24. PubMed ID: 22036304
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Plasmapheresis treatment in Guillain-Barré syndrome: potential benefit over IVIg in patients with axonal involvement.
    Dada MA, Kaplan AA.
    Ther Apher Dial; 2004 Oct; 8(5):409-12. PubMed ID: 15663537
    [Abstract] [Full Text] [Related]

  • 14. [Guillain-Barré syndrome in kidney transplant].
    García Alvarez T, García Herrera A, Mazuecos Blanca A, Lancho Novillo C.
    Nefrologia; 2010 Oct; 30(2):260-1. PubMed ID: 20393626
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Corticosteroids can help distinguish between Guillain-Barré syndrome and first attack of chronic inflammatory demyelinating neuropathy: an illustrative case report.
    Alexander KJ, Alshubaili AF, Santhamoorthy P, Sharafuddin KM.
    Med Princ Pract; 2008 Oct; 17(5):422-4. PubMed ID: 18685286
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Adverse effects of intravenous human polyvalent immunoglobulins].
    Chapuis C, Guy N, Besson G.
    Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.